Scarica l'app Stockscreener
5.17
2.08%
-0.11
Pre-mercato:
5.79
0.62
+11.99%
Precedente Chiudi:
$5.28
Aprire:
$5.35
Volume 24 ore:
111.66K
Relative Volume:
1.21
Capitalizzazione di mercato:
$195.55M
Reddito:
$2.76M
Utile/perdita netta:
$-49.12M
Rapporto P/E:
-3.4467
EPS:
-1.5
Flusso di cassa netto:
$-46.21M
1 W Prestazione:
-1.90%
1M Prestazione:
+5.08%
6M Prestazione:
-35.62%
1 anno Prestazione:
-40.71%
Intervallo 1D:
$5.01
$5.52
Intervallo di 1 settimana:
$5.01
$5.6966
Portata 52W:
$3.96
$10.06
Orchestra Biomed Holdings Inc Stock (OBIO) Company Profile
Nome
Orchestra Biomed Holdings Inc
Settore
Industria
Telefono
646-343-9298
Indirizzo
150 UNION SQUARE DRIVE, NEW HOPE
Confronta OBIO con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
OBIO
Orchestra Biomed Holdings Inc
|
5.17 | 195.55M | 2.76M | -49.12M | -46.21M | -1.50 |
|
VRTX
Vertex Pharmaceuticals Inc
|
427.89 | 110.19B | 10.63B | -479.80M | -1.35B | -1.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
687.80 | 75.58B | 13.85B | 4.65B | 3.32B | 40.41 |
|
ARGX
Argen X Se Adr
|
647.39 | 38.71B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
264.99 | 34.18B | 2.09B | -332.26M | 16.06M | -2.62 |
|
BNTX
Biontech Se Adr
|
117.25 | 28.11B | 3.30B | -501.07M | 1.03B | -2.1146 |
Orchestra Biomed Holdings Inc Stock (OBIO) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-01-02 | Iniziato | Barclays | Overweight |
| 2024-08-22 | Iniziato | H.C. Wainwright | Buy |
| 2024-07-25 | Iniziato | B. Riley Securities | Buy |
| 2024-01-19 | Iniziato | Jefferies | Buy |
| 2023-02-24 | Iniziato | Piper Sandler | Overweight |
| 2023-02-07 | Iniziato | Chardan Capital Markets | Buy |
Mostra tutto
Orchestra Biomed Holdings Inc Borsa (OBIO) Ultime notizie
Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO) Shares Sold by Jane Street Group LLC - Defense World
Geode Capital Management LLC Purchases 11,002 Shares of Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO) - Defense World
Barclays PLC Increases Stake in Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO) - Defense World
Orchestra BioMed (NASDAQ:OBIO) Coverage Initiated by Analysts at Barclays - Defense World
Barclays Initiates Coverage of Orchestra BioMed Holdings (OBIO) with Overweight Recommendation - MSN
Orchestra BioMed shares get shot in the arm on solid clinical trial data - Mugglehead
US Penny Stocks Spotlight: AC Immune And Two Others To Consider - Simply Wall St
Orchestra BioMed Up 49% After Barclays Starts Coverage With $16 Target - MarketWatch
Stock market news: Rain Oncology +371.17%, SuperCom +75.93% among top gainers during mid day trading - Business Upturn
Orchestra BioMed (NASDAQ:OBIO) Now Covered by Barclays - MarketBeat
This Kopin Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday - Benzinga
Orchestra Orchestra BioMed stock rated Overweight on novel medtech model By Investing.com - Investing.com Nigeria
State Street Corp Has $2.21 Million Stock Holdings in Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO) - Defense World
Orchestra Biomed CEO David Hochman buys $18,640 in common stock By Investing.com - Investing.com Australia
Orchestra Biomed CEO David Hochman buys $18,640 in common stock - Investing.com India
Insider Buying: Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO) Insider Purchases 4,000 Shares of Stock - MarketBeat
Orchestra BioMed Holdings, Inc.'s (NASDAQ:OBIO) top owners are individual investors with 26% stake, while 22% is held by hedge funds - Yahoo Finance
Orchestra BioMed CFO Taylor Lawrence buys $4,830 in company stock - Investing.com
Orchestra Biomed CEO David Hochman buys $24,550 in stock By Investing.com - Investing.com Canada
Orchestra Biomed CEO David Hochman buys $24,550 in stock - Investing.com India
Insider Buying: Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO) Insider Acquires 5,000 Shares of Stock - MarketBeat
Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO) Shares Bought by Charles Schwab Investment Management Inc. - Defense World
Here's Why We're Watching Orchestra BioMed Holdings' (NASDAQ:OBIO) Cash Burn Situation - Simply Wall St
Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO) Stock Position Lowered by The Manufacturers Life Insurance Company - Defense World
(OBIO) Pivots Trading Plans and Risk Controls - Stock Traders Daily
OBIOOrchestra BioMed Holdings, Inc. Ordinary Shares Latest Stock News & Market Updates - StockTitan
Orchestra BioMed Announces AVIM Therapy Program Presentations at ICI Meeting - GlobeNewswire
Orchestra BioMed to Present Breakthrough AVIM Therapy Data for Hypertension Treatment at ICI 2024 - StockTitan
Orchestra BioMed Holdings, Inc. (OBIO) Reports Q3 Loss, Tops Revenue Estimates - MSN
RTW Investments LP Has $42.18 Million Stock Holdings in Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO) - MarketBeat
Orchestra BioMed to Participate in the Piper Sandler 36th Annual Healthcare Conference - GlobeNewswire
Orchestra BioMed to Present at Piper Sandler Healthcare Conference | OBIO Stock News - StockTitan
Orchestra BioMed to Present at Jefferies London Healthcare Conference - MSN
HC Wainwright Has Positive Estimate for OBIO FY2024 Earnings - MarketBeat
HC Wainwright Has Optimistic Outlook of OBIO FY2024 Earnings - Defense World
Research Analysts Offer Predictions for OBIO FY2024 Earnings - Defense World
What is Chardan Capital's Forecast for OBIO FY2024 Earnings? - MarketBeat
B. Riley Lifts Earnings Estimates for Orchestra BioMed - MarketBeat
Orchestra BioMed (NASDAQ:OBIO) Earns "Buy" Rating from HC Wainwright - MarketBeat
Chardan Capital Reaffirms Buy Rating for Orchestra BioMed (NASDAQ:OBIO) - Defense World
Orchestra BioMed Holdings Third Quarter 2024 Earnings: Beats Expectations - Yahoo Finance
We Think Orchestra BioMed Holdings (NASDAQ:OBIO) Needs To Drive Business Growth Carefully - Yahoo Finance
Orchestra BioMed Reports Q3 2024 Results, Advances Key Clinical Programs - MSN
Orchestra Biomed Reports Q3 2024 Financial Results - TipRanks
Orchestra BioMed Reports Third Quarter 2024 Financial Results and Provides a Business Update - GlobeNewswire
Orchestra BioMed Q3 Revenue Jumps 150%, Extends Cash Runway Despite Wider Losses | OBIO Stock News - StockTitan
Orchestra Biomed Holdings Inc Azioni (OBIO) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
4.81%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):